Generating Human Organs via Interspecies Chimera Formation: Advances and Barriers.

Area of Science:

• Regenerative Medicine
• Developmental Biology
• Bioengineering

Background:

• The critical shortage of human organs for transplantation presents a significant medical challenge.
• Patient-specific pluripotent stem (PS) cells offer potential for an unlimited supply of donor cells.
• Current methods for generating organs from PS cells in vitro have not yet been successful.

Purpose of the Study:

• To review recent advancements in interspecies blastocyst complementation for generating human organs.
• To identify key challenges and future directions for translating this technology into clinical practice.

Main Methods:

• Interspecies blastocyst complementation involves injecting human PS cells into host animal embryos.
• Genome editing (e.g., CRISPR/Cas9) is used to knock out genes essential for organ development in the host.
• This creates a niche for human PS cells to populate and develop into a specific organ.

Main Results:

• CRISPR/Cas9 technology has advanced the creation of transgenic large animals like pigs and sheep.
• The generation of chimera-competent human PS cells requires further improvement.
• Understanding and overcoming the species barrier that limits human cell colonization in animal embryos is crucial.

Conclusions:

• Interspecies blastocyst complementation is a promising strategy to address the organ donor shortage.
• Further research is essential to enhance human PS cell competence and define interspecies compatibility.
• Successful implementation could revolutionize organ transplantation and save lives.